SPC105
Obinutuzumab og öll afbrigði þess
Status:
AfskrifuðApplication date:
13.1.2015Application published:
15.2.2015
Medicine name:
GazyvaroMedicine for children:
No
Timeline
Today
13.1.2015Application
15.2.2015Publication
Marketing license
IS authorization number:
EU/1/14/937/001Date:
15.8.2014
Foreign authorization number:
EU/1/14/937Date:
24.7.2014
Owner
Name:
Roche Glycart AGAddress:
Wagistrasse 18, Schlieren-Zuerich CH
Agent
Name:
Örn Þór slf.Address:
Klukkuvöllum 17, 221 Hafnarfirði
Patent
Number:
EP1692182